Drug Shortage Report for CEFTIN - TAB 250MG
Report ID | 35768 |
Drug Identification Number | 02212277 |
Brand name | CEFTIN - TAB 250MG |
Common or Proper name | cefuroxime axetil tablets |
Company Name | GLAXOSMITHKLINE INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CEFUROXIME |
Strength(s) | 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 60's |
ATC code | J01DC |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-01-11 |
Estimated end date | Unknown |
Actual end date | 2020-07-20 |
Shortage status | Resolved |
Updated date | 2020-07-24 |
Company comments | product has been discontinued. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2018-04-04 | English | Compare |
v2 | 2018-01-12 | French | Compare |
v1 | 2018-01-12 | English | Compare |